82 related articles for article (PubMed ID: 25273131)
1. Prophylactic effect of the oral administration of transgenic rice seeds containing altered peptide ligands of type II collagen on rheumatoid arthritis.
Iizuka M; Wakasa Y; Tsuboi H; Asashima H; Hirota T; Kondo Y; Matsumoto I; Sumida T; Takaiwa F
Biosci Biotechnol Biochem; 2014; 78(10):1662-8. PubMed ID: 25273131
[TBL] [Abstract][Full Text] [Related]
2. Suppression of collagen-induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands of type II collagen.
Iizuka M; Wakasa Y; Tsuboi H; Asashima H; Hirota T; Kondo Y; Matsumoto I; Takaiwa F; Sumida T
Plant Biotechnol J; 2014 Oct; 12(8):1143-52. PubMed ID: 24989432
[TBL] [Abstract][Full Text] [Related]
3. [Suppression of GPI-induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands].
Hirota T; Tsuboi H; Takahashi H; Asashima H; Ohta M; Wakasa Y; Matsumoto I; Takaiwa F; Sumida T
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):28-34. PubMed ID: 28539551
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
5. Suppression of glucose-6-phosphate-isomerase induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands of glucose-6-phosphate-isomerase.
Hirota T; Tsuboi H; Iizuka-Koga M; Takahashi H; Asashima H; Yokosawa M; Kondo Y; Ohta M; Wakasa Y; Matsumoto I; Takaiwa F; Sumida T
Mod Rheumatol; 2017 May; 27(3):457-465. PubMed ID: 27539357
[TBL] [Abstract][Full Text] [Related]
6. Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.
Sakurai Y; Brand DD; Tang B; Rosloniec EF; Stuart JM; Kang AH; Myers LK
Arthritis Res Ther; 2006; 8(5):R150. PubMed ID: 16982003
[TBL] [Abstract][Full Text] [Related]
7. Transgenic rice seeds expressing altered peptide ligands against the M3 muscarinic acetylcholine receptor suppress experimental sialadenitis-like Sjögren's syndrome.
Kudo H; Tsuboi H; Asashima H; Takahashi H; Ono Y; Abe S; Honda F; Kondo Y; Wakasa Y; Takaiwa F; Takano M; Matsui M; Matsumoto I; Sumida T
Mod Rheumatol; 2020 Sep; 30(5):884-893. PubMed ID: 31490711
[No Abstract] [Full Text] [Related]
8. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.
Myers LK; Sakurai Y; Tang B; He X; Rosloniec EF; Stuart JM; Kang AH
Arthritis Rheum; 2002 Dec; 46(12):3369-77. PubMed ID: 12483744
[TBL] [Abstract][Full Text] [Related]
9. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis.
Myers LK; Tang B; Rosloniec EF; Stuart JM; Chiang TM; Kang AH
J Immunol; 1998 Oct; 161(7):3589-95. PubMed ID: 9759881
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of transgenic rice seeds accumulating a type II-collagen tolerogenic peptide.
Hashizume F; Hino S; Kakehashi M; Okajima T; Nadano D; Aoki N; Matsuda T
Transgenic Res; 2008 Dec; 17(6):1117-29. PubMed ID: 18563612
[TBL] [Abstract][Full Text] [Related]
12. Altered collagen II 263-272 peptide immunization induces inhibition of collagen-induced arthritis through a shift toward Th2-type response.
Li R; Li X; Li Z
Tissue Antigens; 2009 Apr; 73(4):341-7. PubMed ID: 19317744
[TBL] [Abstract][Full Text] [Related]
13. The influence of HLA-DR4 (0401) on the immune response to type II collagen and the development of collagen induced arthritis in mice.
Wang D; Hill JA; Cairns E; Bell DA
J Autoimmun; 2002 Mar; 18(2):95-103. PubMed ID: 11908942
[TBL] [Abstract][Full Text] [Related]
14. Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis.
Min SY; Park KS; Cho ML; Kang JW; Cho YG; Hwang SY; Park MJ; Yoon CH; Min JK; Lee SH; Park SH; Kim HY
Arthritis Rheum; 2006 Mar; 54(3):887-98. PubMed ID: 16508971
[TBL] [Abstract][Full Text] [Related]
15. Absence of in vitro responses to type II collagen by splenocytes from arthritic BALB/c mice is possibly caused by intrinsic CD25+ regulatory cells.
Bäckström F; Dahlgren U
Scand J Immunol; 2008 Apr; 67(4):362-9. PubMed ID: 18248529
[TBL] [Abstract][Full Text] [Related]
16. Epicutaneous immunization with type II collagen inhibits both onset and progression of chronic collagen-induced arthritis.
Strid J; Tan LA; Strobel S; Londei M; Callard R
PLoS One; 2007 Apr; 2(4):e387. PubMed ID: 17440622
[TBL] [Abstract][Full Text] [Related]
17. Breaking T cell tolerance against self type II collagen in HLA-DR4-transgenic mice and development of autoimmune arthritis.
Batsalova T; Dzhambazov B; Merky P; Bäcklund A; Bäcklund J
Arthritis Rheum; 2010 Jul; 62(7):1911-20. PubMed ID: 20309862
[TBL] [Abstract][Full Text] [Related]
18. Mice producing less reactive oxygen species are relatively resistant to collagen glycopeptide vaccination against arthritis.
Batsalova T; Dzhambazov B; Klaczkowska D; Holmdahl R
J Immunol; 2010 Sep; 185(5):2701-9. PubMed ID: 20686129
[TBL] [Abstract][Full Text] [Related]
19. Torilin ameliorates type II collagen-induced arthritis in mouse model of rheumatoid arthritis.
Endale M; Lee WM; Kwak YS; Kim NM; Kim BK; Kim SH; Cho J; Kim S; Park SC; Yun BS; Ko D; Rhee M
Int Immunopharmacol; 2013 Jun; 16(2):232-42. PubMed ID: 23623942
[TBL] [Abstract][Full Text] [Related]
20. Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis.
Bäcklund J; Treschow A; Bockermann R; Holm B; Holm L; Issazadeh-Navikas S; Kihlberg J; Holmdahl R
Eur J Immunol; 2002 Dec; 32(12):3776-84. PubMed ID: 12516572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
